can you mix retatrutide with tirzepatide vs. Tirzepatide: What's The Difference? – Forbes Health Retatrutide Explained for Beginners: Moving

Push the plunger slowly and steadily

Retatrutide (development code LY3437943) is an investigational once-weekly injectable weight loss medication developed by Eli Lilly and Company the same pharmaceutical company behind Mounjaro (tirzepatide) and the oral GLP-1 pill orforglipron (Foundayo)

The MHRA and EMA include pancreatitis warnings in prescribing information, though current evidence suggests benefits generally outweigh risks in appropriately selected patients

If tolerated and under the supervision of your prescriber, your dose may be increased to 5mg weekly then after a further four weeks, it may be increased by another 2.5mg up to a maximum dose of 15 mg once weekly